Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Cortecs granted patent for Flustat

Aug. 29, 1997

Cel-Sci reaches supply agreement with American Red Cross

Aug. 26, 1997

Vertex discloses a novel series of ICE inhibitors

Aug. 25, 1997

TNF-alpha inhibitors reported by Centocor

Aug. 21, 1997

Infanrix Hep B approved in all EU countries

Aug. 19, 1997

Twinrix now available for pediatric use

Aug. 18, 1997

IL-1ra tested for corneal transplant

Aug. 7, 1997

Alpha-Beta Technology's Betafectin shows efficacy in phase III trial

Aug. 6, 1997

Procept awarded grant for tuberculosis vaccine research

Aug. 5, 1997

Vertex acquires ICE patent portfolio from Sanofi

Aug. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...